免疫检查点抑制剂以及针对晚期细胞癌的向治疗的推理
Siwei Yang1, Xianrui Yang1, Zekai Hou1
1Department of Urology, Tianjin Institute of Urology, Second Hospital of Tianjin Medical University, Tianjin, China.
Heliyon
|April 16, 2024
概括
晚期细胞癌 (RCC) 治疗正在发展. 结合免疫检查点抑制剂 (ICI) 和向治疗,有望改善晚期RCC的结果,尽管目前的局限性.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 免疫治疗是一种免疫疗法.
背景情况:
- 细胞癌 (RCC) 是一种具有高转移潜力的致死性尿道恶性瘤.
- 晚期RCC的治疗已经从细胞因子疗法发展到向药物和免疫检查点抑制剂 (ICI).
- 目前的ICI显示有效性,但面临诸如耐药性和副作用等挑战.
研究的目的:
- 审查结合ICI与高级RCC的向治疗的原则和临床进展.
- 探索RCC中的血管生成和瘤微环境的变异.
- 概述先进的RCC治疗的未来研究方向.
主要方法:
- 对临床试验和研究先进的RCC治疗的文献综述.
- 分析涉及ICI,向治疗,血管新生和瘤微环境的机制.
- 综合目前的临床进展和未来的治疗策略.
主要成果:
- 结合治疗ICI和向药物是研究高级RCC的一个关键领域.
- 了解瘤微环境变异对于优化治疗至关重要.
- 新兴的策略旨在克服耐药性并减少副作用.
结论:
- 将ICI与向治疗结合起来,代表了先进RCC治疗的前沿前沿.
- 对血管生成和瘤微环境调节的进一步研究是必不可少的.
- 优化组合策略有可能改善晚期RCC患者的治疗结果.
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K